⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Prisma Biotech Corporation and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Prisma Biotech Corporation
↗Taipei, Taiwan
Prisma Biotech is a prominent Taiwan-based distributor and service provider specializing in clinical genomics, in-vitro diagnostics (IVD), and life science research tools. Founded in 1995, the company acts as a strategic partner for international biotech firms looking to enter the Asian-Pacific market, offering comprehensive solutions that include laboratory equipment, diagnostic reagents, and technical support.
The company is well-regarded for its role in enabling advanced molecular biology and clinical research, including NGS (Next-Generation Sequencing) workflows, reproductive genomics, and single-cell sequencing. Prisma Biotech bridges the gap between global technology providers and local research institutions, universities, and hospitals by providing end-to-end support from experimental design to technical training.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Life Science Distribution & Services
SIZE & FINANCIALS
Employees:1-50
Revenue:$1M-$5M
Founded:1995
Ownership:private
Status:operating
PIPELINE
Modalities:Genomics, Molecular Diagnostics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:ForDx Inc (Japan)
Key Partnerships:Illumina (Genomics/NGS), Parse Biosciences (Single-cell sequencing), BC Platforms (Data management), BioDot (IVD equipment)
COMPETITION
Position:Niche Player
Competitors:Local life science distributors in Taiwan
LEADERSHIP
Key Executives:
Kevin H.P. Tseng - CEO
LINKS
Website:prismabiotech.com.tw
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Prisma Biotech Corporation. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.